Reference gene selection for clinical chimeric antigen receptor T-cell product vector copy number assays-Reference-Cited by-同舟云学术

Reference gene selection for clinical chimeric antigen receptor T-cell product vector copy number assays

Published:2023-06 Issue:6 Volume:25 Page:598-604
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Ma Jinxia,Shao Lipei^ORCID,Fuksenko Tatyana,Liu Hui,Shi Rongye,Dinh Anh,Highfill Steven L.,Zhang Nan,Panch Sandhya R.,Somerville Robert P.,Stroncek David F.,Jin Ping

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics (clinical),Oncology,Immunology,Immunology and Allergy

Reference32 articles.

1. CD19 antigen in leukemia and lymphoma diagnosis and immunotherapy;Scheuermann;Leuk Lymphoma,1995

2. Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19;Kochenderfer;Blood,2010

3. CAR T-cell therapy is effective for CD19-dim B-lymphoblastic leukemia but is impacted by prior blinatumomab therapy;Pillai;Blood Advances,2019

4. CD19-targeted CAR regulatory T cells suppress B cell pathology without GvHD;Imura;JCI Insight,2020

5. Manufacturing validation of biologically functional T cells targeted to CD19 antigen for autologous adoptive cell therapy;Hollyman;J Immunother,2009

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel liquid biopsy CNV biomarkers in malignant melanoma;Scientific Reports;2024-07-09

2. Harnessing eukaryotic retroelement proteins for transgene insertion into human safe-harbor loci;Nature Biotechnology;2024-02-20

3. Clinically accessible amplitude-based multiplex ddPCR assay for tryptase genotyping;Scientific Reports;2024-01-29

4. Regeneration and anti-inflammatory effects of stem cells and their extracellular vesicles in gynecological diseases;Biomedicine & Pharmacotherapy;2023-12

5. Advancement in precision diagnosis and therapeutic for triple-negative breast cancer: Harnessing diagnostic potential of CRISPR-cas & engineered CAR T-cells mediated therapeutics;Environmental Research;2023-10